189 related articles for article (PubMed ID: 28553095)
21. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.
Perotin JM; Leroy S; Marquette CH; Mal H; Dutau H; Bourdin A; Vergnon JM; Pison C; Barbe C; Deslee G;
Int J Chron Obstruct Pulmon Dis; 2018; 13():3645-3649. PubMed ID: 30464447
[TBL] [Abstract][Full Text] [Related]
22. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.
Chai CS; Liam CK; Pang YK; Ng DL; Tan SB; Wong TS; Sia JE
Int J Chron Obstruct Pulmon Dis; 2019; 14():565-573. PubMed ID: 30880946
[TBL] [Abstract][Full Text] [Related]
23. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
Respir Res; 2012 Sep; 13(1):85. PubMed ID: 23006638
[TBL] [Abstract][Full Text] [Related]
24. Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
Karl FM; Holle R; Bals R; Greulich T; Jörres RA; Karch A; Koch A; Karrasch S; Leidl R; Schulz H; Vogelmeier C; Wacker ME;
Respir Res; 2017 Apr; 18(1):60. PubMed ID: 28416015
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary
Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status.
Tejwani V; Nowacki AS; Fye E; Sanders C; Stoller JK
Respir Care; 2019 Aug; 64(8):915-922. PubMed ID: 30914495
[TBL] [Abstract][Full Text] [Related]
27. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
28. Exacerbation frequency and course of COPD.
Halpin DM; Decramer M; Celli B; Kesten S; Liu D; Tashkin DP
Int J Chron Obstruct Pulmon Dis; 2012; 7():653-61. PubMed ID: 23055714
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.
Manca S; Rodriguez E; Huerta A; Torres M; Lazaro L; Curi S; Pirina P; Miravitlles M
COPD; 2014 Sep; 11(5):480-8. PubMed ID: 24832005
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life associates with change in FEV
Lutter JI; Jörres RA; Kahnert K; Schwarzkopf L; Studnicka M; Karrasch S; Schulz H; Vogelmeier CF; Holle R;
BMC Pulm Med; 2020 May; 20(1):148. PubMed ID: 32471493
[TBL] [Abstract][Full Text] [Related]
31. The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ).
Dowson LJ; Guest PJ; Stockley RA
Chest; 2002 Oct; 122(4):1247-55. PubMed ID: 12377849
[TBL] [Abstract][Full Text] [Related]
32. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
33. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
[TBL] [Abstract][Full Text] [Related]
34. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
35. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Miravitlles M; Turner AM; Torres-Duran M; Tanash H; Rodríguez-García C; López-Campos JL; Chlumsky J; Guimaraes C; Rodríguez-Hermosa JL; Corsico A; Martinez-González C; Hernández-Pérez JM; Bustamante A; Parr DG; Casas-Maldonado F; Hecimovic A; Janssens W; Lara B; Barrecheguren M; González C; Stolk J; Esquinas C; Clarenbach CF
Respir Res; 2022 Dec; 23(1):352. PubMed ID: 36527073
[TBL] [Abstract][Full Text] [Related]
36. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.
Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE).
Hogarth DK; Delage A; Zgoda MA; Nsiah-Dosu S; Himes D; Reed MF
Respir Med; 2024 Apr; 224():107565. PubMed ID: 38364975
[TBL] [Abstract][Full Text] [Related]
38. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
39. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.
Holm KE; Borson S; Sandhaus RA; Ford DW; Strange C; Bowler RP; Make BJ; Wamboldt FS
COPD; 2013 Apr; 10(2):226-34. PubMed ID: 23547634
[TBL] [Abstract][Full Text] [Related]
40. Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status.
Ekström M; Tanash H
Int J Chron Obstruct Pulmon Dis; 2017; 12():3281-3287. PubMed ID: 29158672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
